The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

Delcath Systems (DCTH) announced the publication of results from subgroup analyses of the phase 3 FOCUS study. The publication was published in ...

Background Suicide is a leading cause of death among young adults in South Korea. We investigated the association between ...

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...

Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison ...

Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a mid-stage trial, adding to a string of trial and regulatory setbacks for the drugmaker this year.

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

Case Examples of Bayesian Study Designs Used to Accelerate Assessments of Device Safety and Efficacy in SHD Receive the the latest news, research, and presentations from major meetings right to your ...

Garching / Munich, Germany, October 17, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that post hoc subgroup analyses data from its ...

Abstract: The evaluation of spoken language understanding (SLU) systems is often restricted to assessing their global performance or examining predefined subgroups of interest. However, a more ...

LUGANO, Switzerland — Patients with diffuse large B-cell lymphoma (DLBCL) in a genetic subgroup associated with worse outcomes show significantly greater responses to treatment with the standard first ...

Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory properties. Nerandomilast has been shown to slow the ...